114 related articles for article (PubMed ID: 38375588)
1. Design, synthesis and evaluation of aminothiazole derivatives as potential anti-Alzheimer's candidates.
Soni A; Kumar A; Kumar V; Rawat R; Eyupoglu V
Future Med Chem; 2024 Mar; 16(6):513-529. PubMed ID: 38375588
[No Abstract] [Full Text] [Related]
2. Synthesis and molecular docking simulation of new benzimidazole-thiazole hybrids as cholinesterase inhibitors.
Dawood DH; Srour AM; Omar MA; Farghaly TA; El-Shiekh RA
Arch Pharm (Weinheim); 2024 Jan; 357(1):e2300201. PubMed ID: 37937360
[TBL] [Abstract][Full Text] [Related]
3. Design Synthesis and
Remya RS; Ramalakshmi N; Nalini CN; Niraimathi V; Amuthalakshmi S
Curr Comput Aided Drug Des; 2022; 18(4):271-292. PubMed ID: 35927818
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of multitarget new 2-aminothiazole derivatives as potential anti-Alzheimer's agents.
Bardakkaya M; Kilic B; Sagkan RI; Aksakal F; Shakila S; Dogruer DS
Arch Pharm (Weinheim); 2023 Aug; 356(8):e2300054. PubMed ID: 37276369
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis and Biological Evaluation of Xanthone Derivatives for Possible Treatment of Alzheimer's Disease Based on Multi-Target Strategy.
Yang A; Yu Q; Ju H; Song L; Kou X; Shen R
Chem Biodivers; 2020 Oct; 17(10):e2000442. PubMed ID: 32692899
[TBL] [Abstract][Full Text] [Related]
6. New thiourea and benzamide derivatives of 2-aminothiazole as multi-target agents against Alzheimer's disease: Design, synthesis, and biological evaluation.
Kilic B; Bardakkaya M; Ilıkcı Sagkan R; Aksakal F; Shakila S; Dogruer DS
Bioorg Chem; 2023 Feb; 131():106322. PubMed ID: 36565675
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, in vitro and in silico evaluations of new isatin-triazine- aniline hybrids as potent anti- Alzheimer multi-target directed lead compounds.
Tamaddon-Abibigloo Y; Dastmalchi S; Razzaghi-Asl N; Shahbazi Mojarrad J
Bioorg Chem; 2024 Jun; 147():107355. PubMed ID: 38657528
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.
Riazimontazer E; Sadeghpour H; Nadri H; Sakhteman A; Tüylü Küçükkılınç T; Miri R; Edraki N
Bioorg Chem; 2019 Aug; 89():103006. PubMed ID: 31158577
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and anti-Alzheimer's disease activity study of xanthone derivatives based on multi-target strategy.
Kou X; Song L; Wang Y; Yu Q; Ju H; Yang A; Shen R
Bioorg Med Chem Lett; 2020 Feb; 30(4):126927. PubMed ID: 31901382
[TBL] [Abstract][Full Text] [Related]
10. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors:
Makhaeva GF; Kovaleva NV; Boltneva NP; Rudakova EV; Lushchekina SV; Astakhova TY; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Korabecny J; Soukup O; Bachurin SO; Richardson RJ
Molecules; 2022 Feb; 27(3):. PubMed ID: 35164325
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional novel Diallyl disulfide (DADS) derivatives with β-amyloid-reducing, cholinergic, antioxidant and metal chelating properties for the treatment of Alzheimer's disease.
Manral A; Saini V; Meena P; Tiwari M
Bioorg Med Chem; 2015 Oct; 23(19):6389-403. PubMed ID: 26337018
[TBL] [Abstract][Full Text] [Related]
12. Design, Synthesis and Biological Evaluation of New Cycloalkyl Fused Quinolines Tethered to Isatin Schiff Bases as Cholinesterase Inhibitors.
Macha B; Kulkarni R; Garige AK; Palabindala R; Akkinepally R; Garlapati A
Comb Chem High Throughput Screen; 2022; 25(1):167-186. PubMed ID: 33308120
[TBL] [Abstract][Full Text] [Related]
13. Potential of aryl-urea-benzofuranylthiazoles hybrids as multitasking agents in Alzheimer's disease.
Kurt BZ; Gazioglu I; Basile L; Sonmez F; Ginex T; Kucukislamoglu M; Guccione S
Eur J Med Chem; 2015 Sep; 102():80-92. PubMed ID: 26244990
[TBL] [Abstract][Full Text] [Related]
14. Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer's disease treatment.
Makhaeva GF; Lushchekina SV; Kovaleva NV; Yu Astakhova T; Boltneva NP; Rudakova EV; Serebryakova OG; Proshin AN; Serkov IV; Trofimova TP; Tafeenko VA; Radchenko EV; Palyulin VA; Fisenko VP; Korábečný J; Soukup O; Richardson RJ
Bioorg Chem; 2021 Jul; 112():104974. PubMed ID: 34029971
[TBL] [Abstract][Full Text] [Related]
15. Potent acetylcholinesterase inhibitors: design, synthesis, biological evaluation, and docking study of acridone linked to 1,2,3-triazole derivatives.
Mohammadi-Khanaposhtani M; Saeedi M; Zafarghandi NS; Mahdavi M; Sabourian R; Razkenari EK; Alinezhad H; Khanavi M; Foroumadi A; Shafiee A; Akbarzadeh T
Eur J Med Chem; 2015 Mar; 92():799-806. PubMed ID: 25636055
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, and Evaluation of Novel 2
Haji Ali S; Osmaniye D; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA
Molecules; 2022 Mar; 27(7):. PubMed ID: 35408519
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and evaluation of some N-methylenebenzenamine derivatives as selective acetylcholinesterase (AChE) inhibitor and antioxidant to enhance learning and memory.
Shrivastava SK; Srivastava P; Upendra TVR; Tripathi PN; Sinha SK
Bioorg Med Chem; 2017 Feb; 25(4):1471-1480. PubMed ID: 28126439
[TBL] [Abstract][Full Text] [Related]
18. Molecular docking, synthesis and biological evaluation of phenacyl derivatives of 9-aminoacridine as anti-Alzheimer's agent.
Munawar R; Mushtaq N; Ahmad A; Saeed SMG; Usmani S; Akhtar S; Saify ZS; Arif M; Akram A
Pak J Pharm Sci; 2020 Mar; 33(2):659-668. PubMed ID: 32276912
[TBL] [Abstract][Full Text] [Related]
19. Conjugates of tacrine and 1,2,4-thiadiazole derivatives as new potential multifunctional agents for Alzheimer's disease treatment: Synthesis, quantum-chemical characterization, molecular docking, and biological evaluation.
Makhaeva GF; Kovaleva NV; Boltneva NP; Lushchekina SV; Rudakova EV; Stupina TS; Terentiev AA; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Bachurin SO; Richardson RJ
Bioorg Chem; 2020 Jan; 94():103387. PubMed ID: 31735356
[TBL] [Abstract][Full Text] [Related]
20. 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
Makhaeva GF; Lushchekina SV; Boltneva NP; Serebryakova OG; Rudakova EV; Ustyugov AA; Bachurin SO; Shchepochkin AV; Chupakhin ON; Charushin VN; Richardson RJ
Bioorg Med Chem; 2017 Nov; 25(21):5981-5994. PubMed ID: 28986116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
